• Nachrichtendetail
• 

18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	MERCK CO. DL-,01	A0YD8Q	Xetra	116,200	25.07.24 09:04:03	+0,800	+0,69%	116,000	116,600	116,200	115,400
	LIGAND PHARMAC.NEW DL-001	A1C9RN	Frankfurt	95,000	25.07.24 08:50:26	+1,500	+1,60%	95,000	95,500	95,000	93,500